Tenaya Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Tenaya Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q2 2021 to Q3 2024.
  • Tenaya Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $12.6M, a 35.2% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $12.6M +$3.29M +35.2% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $13.7M +$3.52M +34.8% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $9.18M -$1.73M -15.9% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $9.98M -$1.68M -14.4% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $9.34M -$3.06M -24.7% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $10.1M -$2.98M -22.7% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $10.9M -$444K -3.91% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $11.7M -$22K -0.19% Dec 31, 2022 10-K 2024-03-18
Q3 2022 $12.4M +$393K +3.27% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $13.1M +$799K +6.49% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $11.4M Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $11.7M Dec 31, 2021 10-K 2023-03-08
Q3 2021 $12M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $12.3M Jun 30, 2021 10-Q 2021-09-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.